Gentium (GENT)

Add to Watchlists Create an Alert
8.49 -0.30  -3.41%   NASDAQ May 23, 8:00PM BATS Real time Currency in USD

Gentium Revenue Quarterly YoY Growth:

37.86% for March 31, 2013
View Full Chart

Gentium Revenue Quarterly YoY Growth Chart

    Gentium Historical Revenue Quarterly YoY Growth Data

    Pro Data Export
    Dates:  to
    Viewing 1 of 1   First  Previous First    Next  Last   Last

    There is no data for the selected date range.

    Data for this Date Range  
    March 31, 2013 37.86%
    Dec. 31, 2012 31.13%
    Sept. 30, 2012 33.56%
    June 30, 2012 9.74%
    March 31, 2012 -11.78%
    Dec. 31, 2011 -6.34%
    Sept. 30, 2011 -10.97%
    June 30, 2011 4.92%
    March 31, 2011 27.50%
    Dec. 31, 2010 39.12%
    Sept. 30, 2010 120.2%
    June 30, 2010 150.2%
    March 31, 2010 400.7%
    Dec. 31, 2009 294.9%
    Sept. 30, 2009 37.10%
    June 30, 2009 24.88%
    March 31, 2009 -68.49%
       
    Dec. 31, 2008 -55.48%
    Sept. 30, 2008 -37.39%
    June 30, 2008 90.18%
    March 31, 2008 Go Pro
    Dec. 31, 2007 Go Pro
    Sept. 30, 2007 Go Pro
    June 30, 2007 Go Pro
    March 31, 2007 Go Pro
    Dec. 31, 2006 Go Pro
    Sept. 30, 2006 Go Pro
    June 30, 2006 Go Pro
    March 31, 2006 Go Pro
    Dec. 31, 2005 Go Pro
    Sept. 30, 2005 Go Pro
    June 30, 2005 Go Pro
    March 31, 2005 Go Pro
    Dec. 31, 2004 Go Pro

    About Revenue Growth

    Revenue growth illustrates sales increases/decreases over time. It is used to measure how fast a business is expanding. More valuable than a snapshot of revenue, revenue growth helps investors identify trends in order to gauge revenue growth over time.

    If a company generated $75 billion in revenue during 2008 and $100 billion in revenue during 2009, the company experienced roughly a ($100 billion/$75 billion)-1 = %33 increase in revenue.
    Learn More

    Get data for

    GENT Revenue Quarterly YoY Growth Benchmarks

    Companies
    Acura Pharmaceuticals
    Horizon Pharma 91.35%
    Sagent Pharmaceuticals 57.29%

    GENT Revenue Quarterly YoY Growth Rankings

    Overall 91st percentile
    642 of 8006
    Sector 84th percentile
    105 of 686 in Healthcare
    Industry 83rd percentile
    11 of 68 in Drug Manufacturers - Specialty & Generic

    GENT Revenue Quarterly YoY Growth Range, Past 5 Years

    Minimum -68.49% Mar 2009
    Maximum 400.7% Mar 2010
    Average 55.57%